Kimberly-Clark's Dividend And Safe Haven Trade Outweigh Post-Merger Risks
Kimberly-Clark's 5% dividend yield and Kenvue merger upside outweigh Tylenol litigation risk after a 30% share-price decline.
NASDAQ
KMB
1 story
$33B Market cap · 2026-09-25
Kimberly-Clark's 5% dividend yield and Kenvue merger upside outweigh Tylenol litigation risk after a 30% share-price decline.
Companies the stories above are also about, besides KMB.